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“…	for	he	grants	sleep	to	those	he	loves”		
	
	Psalms	127:2	
 	
 v 
ACKNOWLEDGMENTS		First,	I	would	like	to	thank	my	advisor,	Professor	Masashi	Yanagisawa,	for	unwavering	support.	He	has	always	been	considerate	of	every	outcome	and	obstacles	and	steered	me	in	the	right	direction.	Also,	to	the	members	of	my	dissertation	committee:	Professor	Akira	Shibuya,	Dr.	Joseph	Takahashi,	and	Dr.	 Kaspar	 Vogt.	 I	 feel	 extremely	 blessed	 to	 work	 with	 such	 wonderful	teachers.	
This	dissertation	is	a	product	of	a	great	teamwork.	I	want	to	thank	all	present	and	past	members	of	the	Yanagisawa/Funato	lab.	Many	deserving	thanks	to	the	 ENU	 group	 members,	 especially	 Dr.	 Hiromasa	 Funato	 and	 Dr.	 Chika	Miyoshi.	Dr.	Funato	has	guided	me	every	step	of	the	way	since	I	joined	the	project,	 never	 failed	 to	 inspire	 me	 as	 an	 aspiring	 researcher.	 Dr.	 Chika	Miyoshi,	with	her	nurturing	 character,	 pulled	me	 through	 the	demanding	days	 of	 mouse	 colony	 management	 and	 screening.	 I	 must	 express	appreciation	for	Ms.	Miyo	Kakizaki	and	Ms.	Noriko	Hotta	for	the	exceptional	craftsmanship	of	mouse	work	they	taught	me.	I	am	also	thankful	for	Ms.	Aya	Ikkyu	and	Ms.	Satomi	Kanno	for	their	assistance	in	the	strenuous	molecular	experiments.	This	 laborious	screening	study	could	not	have	been	possible	without	the	hard	work	of	one	and	each	member	of	the	team.	
I	want	to	take	this	opportunity	to	acknowledge	Dr.	Shigeharu	Wakana	and	Dr.	Takahiro	Ezaki	for	their	support	and	the	expertise	they	brought	into	this	project.		
I	 give	 special	 thanks	 to	my	parents,	my	husband,	my	pastors	 and	 church	family	for	their	love	and	encouragement.	I	could	not	have	achieved	anything	without	their	spiritual	support	and	prayers.	I	am	blessed	with	such	a	faithful	and	trusting	family,	always	cheering	me	to	pursue	my	dream.	
 vi 
ABSTRACT		
The	sleep-wake	cycle	is	an	intricate	process	controlled	by	a	complex	cascade	of	effectors.	The	homeostatic	propensity	to	sleep	increases	as	“sleep	need”	accumulates	during	the	wakeful	state,	driving	animals	to	commence	in	sleep	behavior.	However,	 the	molecular	 and	 cellular	mechanism	 that	 facilitates	such	a	switch	is	 largely	unknown.	In	an	attempt	to	identify	the	regulatory	cascade	of	sleep	and	wake	behavior,	we	established	a	large-scale	screening	system	 based	 on	 EEG	 and	 EMG	 using	 mice	 to	 employ	 forward	 genetics	approach.		
Our	 high-throughput	 screening	 system	 follows	 the	 dominant	 screening	scheme	of	randomly	mutagenized	mice,	which	possesses	major	advantages	when	compared	to	the	more	conventional	recessive	screening	scheme.	This	paper	discusses	the	theoretical	basis	for	the	study	and	presents	the	details	of	the	methodology	and	workflow.	
In	addition	to	Sleepy	and	Dreamless	mutants	reported	by	Funato	et	al.,	our	study	continues	to	reveal	more	candidate	genes,	including	Cacna1a	showing	a	mild	decrease	in	total	wake	time	resulting	from	a	heterozygous	mutation.	Based	 on	 the	 parameters	 tested,	 our	 screening	 system	 is	 modifiable	 for	application	in	any	behavioral	analysis	other	than	sleep/wakefulness.
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SECTION	I:		INTRODUCTION		
Sleep	 is	 a	 ubiquitous	 behavior;	 no	 species	 in	 the	 animal	 kingdom	 with	central	nervous	system	has	been	demonstrated	to	sustain	life	without	sleep	or	a	sleep-like	quiescent	state.	Mammalian	sleep	exhibits	a	cyclic	transition	between	rapid	eye	movement	sleep	(REMS)	and	non-REM	sleep	(NREMS),	defined	by	the	characteristic	brain	activity	and	muscle	tone,	as	measured	by	electroencephalogram	 (EEG)	 and	 electromyogram	 (EMG),	 respectively.	Although	 recent	 advances	 in	 the	 optogenetic	 and	 chemogenetic	manipulation	of	neurons	have	led	to	the	accumulation	of	information	about	executive	neural	 circuitries	 regulating	 sleep	 and	wake	 states	 (Weber	 and	Dan,	 2016),	 the	molecular	 and	 cellular	mechanisms	 that	 drive	 the	 switch	between	wakefulness,	NREMS	and	REMS	remain	a	mystery.	
In	 an	 attempt	 to	 unravel	 the	 regulatory	 mechanism	 of	 sleep	 and	 wake	behavior,	we	established	a	large-scale	sleep	screening	system	based	on	EEG	and	EMG	using	mice	 to	employ	 forward	genetics	approach.	This	 research	strategy	follows	an	unbiased	phenotypic	screening	to	find	the	causal	genetic	relationship	with	the	inherited	trait.	The	first	utilization	of	forward	genetics	in	 behavioral	 biology	 dates	 to	 1970s	when	Drosophila	melanogaster	was	screened	for	aberrant	phenotypes	after	treatment	with	mutagens,	leading	to	groundbreaking	discoveries	including	identification	of	the	period	gene	(Citri	et	al.,	1987;	Konopka	and	Benzer,	1971;	Reddy	et	al.,	1984).	Later,	the	Clock	
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gene	was	discovered	in	mice	using	a	similar	approach	for	the	first	time	(King	et	 al.,	 1997),	 contributing	 hugely	 to	 the	 current	 understanding	 of	 the	circadian	clock	system	(Ripperger	et	al.,	2011;	Takahashi,	2016).	Ever	since	the	 discovery	 that	 flies	 exhibit	 behavior	 states	 that	 qualify	 as	sleep/wakefulness	(Hendricks	et	al.,	2000;	Shaw,	2000),	an	intensive	effort	has	 been	made	 to	 decipher	 sleep	 through	 the	 fly	 genetics	 (Tomita	 et	 al.,	2017).	 Currently	 in	 flies,	 however,	 sleep	 can	 only	 be	 assessed	 through	monitoring	the	 locomotive	activities.	 It	 is	unclear	whether	sleep	in	flies	 is	truly	analogous	to	mammalian	sleep,	in	which	the	gold	standard	in	defining	and	assessing	sleep	is	through	EEG/EMG	analysis.	
The	advantages	in	using	mice	over	fruit	flies	in	sleep	research	include	the	capability	in	reliably	staging	three	vigilance	states,	wakefulness,	NREMS	and	REMS	 through	 EEG/EMG-based	 somnography	 analysis.	 Furthermore,	 the	homology	of	 the	genome	and	brain	 structure	between	mouse	and	human	predicts	a	conserved	mechanism	regulating	sleep/wakefulness.	We	expect	that	 findings	 in	 mice	 can	 be	 applied	 to	 human	 sleep	 physiology	 and	pathology.	For	example,	 since	 its	discovery	 in	1998,	Orexin	has	been	well	established	as	an	essential	regulator	of	wakefulness.	Orexin-deficient	mice	show	multidimensional	 phenotypic	 aberration	 that	 is	 similar	 to	 a	 human	sleep	disorder,	narcolepsy	(Chemelli	et	al.,	1999;	Volpe	and	Ratan,	2007).	This	led	to	the	understanding	of	the	pathophysiology	of	the	disorder	and	to	the	development	of	a	novel	class	of	drug	for	insomnia	(Coleman	et	al.,	2017).	Thus,	the	use	of	mouse	models	has	facilitated	extension	into	understanding	
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human	disease	and	drug	discoveries,	further	emphasizing	the	utility	of	the	murine	model	in	translational	studies.	
Nonetheless,	 there	 are	 obstacles	when	 undertaking	 a	 large-scale	 forward	genetic	study	using	adult	mice	in	comparison	to	simpler	organisms,	such	as	
D.	melanogaster	or	Caenorhabditis	elegans.	Mice	have	generation	time	of	at	least	three	months,	which	is	considerably	longer	than	the	flies	(10-12	days),	and	must	be	kept	under	a	 tightly	controlled	environment.	This	requires	a	high	maintenance	 cost	 for	 husbandry	 and	 labor-intensive.	 Also,	 the	 high-throughput	sleep	analysis	needs	well-trained	research	staff	for	implantation	surgery	 and	 EEG/EMG-based	 sleep	 staging.	 Despite	 these	 difficulties,	advances	in	bioinformatics	and	genome	editing	over	the	last	10	years	have	improved	the	speed	and	feasibility	of	the	forward	genetics	research	in	mice.	Since	the	completion	of	the	whole	mouse	genome	sequencing	(Chinwalla	et	al.,	2002),	a	tremendous	pool	of	information	on	the	genetic	background	of	inbred	mouse	 strains	 is	 available	 including	 a	 genome-wide	 list	 of	 genetic	markers	between	B6J	and	B6N	(Kumar	et	al.,	2013).	Traditionally,	counter	strains	genetically	very	distant	from	the	mutagenized	strain	were	preferred	because	polymorphic	markers	were	more	readily	available.	However,	use	of	such	 distant	 counter	 strains	 became	 unnecessary	 allowing	 us	 to	 use	mutagenized	and	counter	strains	with	genetic	proximity	and	near-identical	phenotype	(Funato	et	al.,	2016;	Hossain	et	al.,	2016).	Most	of	the	phenotype-inducing	mutations	are	a	single	nucleotide	substitution	that	 lie	within	the	coding	 regions.	 Thus,	 whole-exome	 sequencing	 combined	 with	 coarse	
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linkage	analyses	can	immediately	provide	a	list	of	candidate	gene	mutations.	Importantly,	 the	 technical	 advances	 in	 nuclease-mediated	 targeted	mutagenesis,	such	as	CRISPR/Cas9	system,	facilitates	efficient	examination	of	causality	of	an	identified	mutation.	
This	paper	describes	 the	methods	and	workflow	 for	 the	 large-scale,	high-throughput	 screening	 of	 randomly	mutagenized	mice	 for	 sleep	 and	wake	behavior.	 We	 also	 provide	 a	 theoretical	 discussion	 on	 the	 relationship	among	 the	 logarithm	of	 odds	 (LOD)	 score,	 statistical	 significance	 and	 the	extent	of	the	sleep	phenotype.	In	addition,	a	new	pedigree,	Drowsy,	which	carries	a	mutation	in	the	Cacna1a	gene	is	described.	Our	screening	scheme	and	 statistical	 simulation	 of	 the	 phenotype	 is	 modifiable	 for	 any	 type	 of	behavior	and	physiological	screening	other	than	sleep/wakefulness.		 	 	
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SECTION	II:		RESULTS	AND	DISCUSSION	
2.1	Animal	selection	
It	 is	 strategically	and	practically	desirable	 to	 select	 an	appropriate	age	of	animals	to	minimize	housing	and	maintenance	cost.	Screening	younger	mice	may	reduce	 the	cost	of	husbandry,	but	 it	poses	risk	 that	young	mice	may	exhibit	immature	sleep	and	wake	behavior	(Nelson	et	al.,	2013).	Considering	the	 vulnerability	 to	 implantation	 surgery	 and	 maturity	 of	 the	 skull,	 we	performed	 the	 implantation	 surgery	 at	 9-10	weeks	 of	 age	 and	 EEG/EMG	recording	after	7-10	days	of	recovery.	Only	male	mice	were	screened	for	the	strategic	advantage	as	the	number	of	sperms	from	a	single	male	mouse	is	greater	 than	 that	 of	 eggs	 from	 one	 female	 mouse,	 and	 sperm	 can	 be	cryopreserved	relatively	easily.	Also,	male	mice	are	preferred	in	behavioral	studies	due	to	the	chance	of	estrous	cycle	serving	as	a	potential	confounding	factor	 in	 female	 mice,	 and	 therefore	 only	 a	 few	 studies	 have	 examined	sleep/wakefulness	in	female	mice	(Komiya	et	al.,	2018).	
2.2	Choice	of	inbred	strain	
The	proper	choice	of	 inbred	strains	 for	mutagenized	 fathers	and	counter-strain	mothers	is	one	of	the	most	crucial	factors	for	a	successful	screening.	Each	inbred	strain	shows	a	characteristic	sleep/wake	behavior	(Franken	et	al.,	1998,	2001;	Tafti	et	al.,	1999),	which	is	attributed	to	the	presence	of	many	quantitative	trait	loci	(QTL).	A	wide	variance	may	mask	the	effect	of	ENU-
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induced	mutations	if	two	strains	are	not	chosen	carefully.	We	selected	B6J	as	mutagenized	strain	and	B6N	as	counter	strain	because	they	are	very	close	to	 each	 other	 (separated	 only	 ~70	 years	 ago)	 (Figure	 1),	 yet	 the	whole-genome	 sequences	 and	 a	 list	 of	 single	 nucleotide	 polymorphism	 (SNP)	markers	were	available	(Chinwalla	et	al.,	2002;	Kumar	et	al.,	2013).	However,	we	 noticed	 inconsistent	 SNPs	 in	 each	 substrain	 derived	 from	 different	breeders.	 Multiple	 substrains	 were	 sequenced	 to	 generate	 an	 evenly	distributed	list	of	96	SNPs	(Figure	2,	Table	1)	(Mekada	et	al.,	2015).	
To	evaluate	the	similarity	in	the	sleep/wakefulness	between	B6J	and	B6N,	we	examined	two	strains	against	B10J.	Consistent	with	the	genetic	proximity,	B6J	and	B6N	showed	similar	time	spent	in	wakefulness,	NREMS	and	REMS,	whereas	B10J	exhibited	a	shorter	daily	wake	time	accounted	by	change	in	total	 sleep	 time	 (Figure	 3A-C).	 Second	 parameter	 examined	 were	 the	episode	 duration	 of	 each	 vigilance	 state.	 Although	 B6J	 and	 B6N	 showed	similar	episode	duration	over	24-h	 in	wakefulness	and	NREMS,	 the	REMS	episode	durations	in	B6N	mice	was	longer	during	the	light	phase	and	shorter	during	the	dark	phase	(Figure	3D-F).	EEG power spectrum analysis showed a 
similar trend in B6J, B6N, and B10J during NREMS and REMS	(Figure	3G-H).	There	 was	 no	 significant	 difference	 in	 the	 delta	 power	 (1-4	 Hz)	 density	during	NREMS	or	the	theta	power	(6-9	Hz)	density	during	REMS	(Figure	3I-J).	We	also	examined	the	response	 to	sleep	deprivation	 in	each	substrain.	During	 the	 18-h	 recovery	 sleep	 following	 the	 6-h	 sleep	 deprivation	 from	ZT0-6,	 the	 total	 time	 spent	 in	 wake	 during	 dark	 phase	 was	 slightly	 but	
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significantly	longer	in	B6N	with	decrease	in	both	NREMS	and	REMS	(Figure	4A-C).	The	 increase	 in	the	NREMS	and	REMS	time	during	dark	phase	was	similar	 in	 B6J	 and	 B6N,	 but	 significantly	 lower	 in	 B10J	 (Figure	 4D).	 The	NREMS	EEG	delta	 power	 during	 the	 first	 6	 h	 after	 sleep	 deprivation	was	slightly	but	significantly	smaller	in	B6N	(Figure	4E).	Although	this	suggest	that	 B6N	 may	 have	 maginally	 blunted	 homeostatic	 response	 to	 sleep	deprivation,	 it	 would	 be	 difficult	 to	 map	 the	 causal	 loci	 because	 of	 the	relatively	poor	reproducibility	of	these	parameters	(see	below).		
Since	the	difference	in	sleep/wakefulness	between	B6J	and	B6N	strains	 is	very	small,	the	use	of	the	two	strains	as	mutagenized	and	counter	strains	is	optimal	 for	 forward	 genetics	 of	 sleep	 and	 presumably	 suitable	 for	 other	behavioral	 and	 metabolic	 traits	 (Kumar	 et	 al.,	 2013).	 Indeed,	 this	combination	enabled	us	to	identify,	for	the	first	time,	obesogenic	mutations	through	dominant	screening	(Hossain	et	al.,	2016).		
2.3	ENU	dosage	and	mutagenic	effect	
ENU	has	been	the	choice	for	random	mutagenesis	study	in	mice	because	of	its	 high	 potency	 but	 relatively	 weak	 lethality	 (Hitotsumachi	 et	 al.,	 1985;	Russell	et	al.,	1979).	After	the	administration	of	ENU,	mice	enter	a	temporary	sterile	condition	because	the	mutagen	targets	the	spermatogonia.	The	loss	and	 regaining	 of	 fertility	 are	 good	 indication	 of	 the	mutagenic	 effect	 and	induction	of	random	mutations.	The	recovery	time	is	variable	depending	on	the	dosage	and	mouse	strain.	B6	mice	regain	fertility	after	8-12	weeks	but	
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now	 with	 sperms	 carrying	 the	 ENU-induced	 mutations.	 An	 appropriate	dosage	must	be	set	 to	avoid	a	 long-term	influence	of	 this	potent	mutagen	that	may	deteriorate	 the	health	of	 the	animal.	Conversely,	 too	 low	a	dose	would	induce	only	a	small	number	of	mutations.		
The	 initial	 ENU	 administration	 of	 85mg/kg	 body	weight	 twice	 at	weekly	interval	 resulted	 in	 50-70	 mutations	 per	 haploid	 exome	 in	 the	 F1	 as	examined	by	whole	exome	sequencing	(data	not	shown).	However,	many	of	the	G0	mutagenized	mice	remained	fertile.	The	ENU	dosage	was	optimized	based	on	the	updated	standard	protocol	of	weekly	injections	of	100	mg/kg	body	weight	ENU	(Hitotsumachi	et	al.,	1985;	Russell	et	al.,	1979).	At	the	age	of	8	to	10	weeks,	male	B6J	mice	were	treated	with	weekly	intraperitoneal	injection	 of	 ENU	 for	 three	 weeks	 based	 on	 the	 Mutagenetix	 protocol	(http://mutagenetix.utsouthwestern.edu)	 (Wang	 et	 al.,	 2015).	 The	mutagenized	mice	were	subjected	to	routine	sterility	check	by	cohabitating	with	wild-type	female	mice.	
2.4	Screening	strategy	
Many	of	the	large-scale	forward	genetics	studies	in	the	literatures	follow	the	recessive	screening	scheme	(Goldowitz	et	al.,	2004).	This	requires	breeding	of	 three	 generations	 in	 each	 founder	 pedigree	 before	 proceeding	 to	 the	phenotypic	screening.	The	G3	progeny	in	recessive	screening	has	a	chance	of	 either	 1/16	 (intercross	 scheme,	 shaded	 enclosure)	 or	 1/8	 (backcross	scheme,	dotted	enclosure)	(Figure	5A)	to	carry	the	homozygous	mutation.	
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Typically,	 30-50	 G3	 mice	 are	 screened	 per	 pedigree	 to	 reach	 statistical	power	for	linkage	analysis	(Beutler	et	al.,	2007)	requiring	a	massive	amount	of	 resources.	 On	 the	 other	 hand,	 dominant	 screening	 follows	 simpler	workflow,	fewer	generations	from	the	mutagenesis	to	phenotype	screening	and	 a	 smaller	 colony	 size	 requirement	 for	 assessing	 the	 same	number	 of	gene	mutations,	 since	 each	F1	 founder	 represents	 haploid	 genome	of	 the	mutagenized	G0	father	(Siepka	and	Takahashi,	2005).		
In	 our	 dominant	 screening,	 F1	 offspring	 from	 a	 cross	 between	 the	mutagenized	G0	father	(B6J)	and	wild-type	counter	strain	mother	(B6N)	is	screened	for	sleep/wake	phenotype.	The	F1	phenodeviant	is	subsequently	backcrossed	with	wild-type	B6N	female	to	obtain	N2	progeny	for	assessing	heritability	of	the	sleep	abnormality	(Figure	5B).	In	most	cases	(43	out	of	57	pedigrees),	 the	N2	generation	did	not	 inherit	 the	presumptive	phenotype	seen	in	F1	and	showed	normal	sleep/wake	behavior	(Figure	5C,	Phenotype	A).	This	may	be	due	to	a	deviation	by	chance	in	F1	mice	or	a	summed	weak	effect	 diluted	 by	 mating	 with	 wild-type	 mouse.	 When	 the	 inherited	phenotype	is	subtle,	the	histogram	of	sleep	parameters	would	be	similar	to	the	normal	behavior	making	it	difficult	to	determine	the	heritability	(Figure	5C,	Phenodeviant	B).	For	a	heritable	weak-to-moderate	sleep	abnormality,	the	 histogram	 showed	 two	 partially	 overlapped	 peaks	 of	 the	 sleep	parameter,	which	allowed	determining	a	small	number	of	N2	mice	as	either	phenodeviant	 or	 normal,	 and	 many	 remaining	 N2	 mice	 undetermined	(Figure	 5C,	 Phenodeviant	 C).	 When	 the	 pedigree	 had	 a	 strong	 sleep	
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phenotype,	two	non-overlapped	peaks	of	the	sleep	parameter	enabled	us	to	determine	 each	 N2	 mice	 as	 phenodeviant	 and	 normal	 (Figure	 5C,	Phenodeviant	D).	We	proceed	to	quantitative	trait	loci	(QTL)	analysis	when	at	least	20%	of	the	male	N2	littermates	are	determined	as	phenodeviants.	
Given	 that	 sleep	 parameters	 follow	 normal	 distribution,	 the	 expected	incidence	of	mice	outside	3	standard	deviations	(SD)	is	0.003.	At	the	early	stage	of	our	screening,	no	more	than	five	phenodeviants	were	identified	for	every	1,000	mice,	indicating	that	many	of	these	“phenodeviants”	happened	by	 chance.	 The	 chance	 of	 establishing	 heritable	 phenodeviant	 pedigree	would	increase	with	the	higher	number	of	mice	screened.	Thus	far,	we	have	screened	 10,024	 mice	 and	 identified	 57	 phenodeviants.	 Out	 of	 the	 57	pedigrees,	14	are	confirmed	for	the	heritability	of	the	sleep	phenotype	and	mutations	mapped	to	10	loci,	including	5	pedigrees	carrying	the	same	Sik3Slp	allele	 (Funato	 et	 al.,	 2016).	 So	 far	 at	 least	 4	 independent	 causative	 gene	mutations	have	been	validated.	
Strategically,	 dominant	 screening	 presents	 advantages	 over	 recessive	screening	that	include	simpler	workflow	and	substantially	less	requirement	of	 resources	 for	 mouse	 propagation	 and	 maintenance.	 The	 inherent	challenge	 in	 dominant	 screening	 is	 the	 low	 frequency	 of	 obtaining	 mice	showing	the	heritable	phenotypes	compared	with	recessive	screening.	This	may	 partly	 be	 due	 to	 the	 presence	 of	 the	 wild-type	 allele	 or	 the	 low	penetrance	 of	 the	 gene	 mutation	 (Nolan	 et	 al.,	 1997).	 Gain-of-function	
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mutations	may	sometimes	fail	to	reflect	the	endogenous	function	of	the	gene	of	interest,	especially	in	disease	manifestation	by	a	neomorphic	type	of	allele.	On	the	other	hand,	screens	 for	dominant	mutants	will,	 in	many	 instances,	reveal	 semi-dominance	 of	 the	 allele.	 Some	 of	 these	 mutations	 are	antimorphic	 in	 nature,	 and	 can	 be	 critical	 in	 understanding	 the	 gene’s	function	as	 in	 the	case	of	 the	Clock	ENU	mutant;	 the	 function	of	 the	Clock	gene	would	never	have	been	considered	based	on	the	knockout	phenotype	alone	 (DeBruyne	 et	 al.,	 2006;	King	 et	 al.,	 1997).	 In	 addition,	 homozygous	mutations	often	lead	to	lethality	or	severe	disease,	preventing	examination	of	sleep/wake	phenotype,	as	in	the	case	of	the	Cacna1a	(Drowsy)	mutation	(see	 below)	 (Hayasaka	 et	 al.,	 2017;	 Uebi	 et	 al.,	 2012).	 Indeed,	 genetic	mutations	identified	in	the	heritable	sleep	disorder,	such	as	familial	advance	sleep	phase	(FASP),	show	autosomal-dominant	inheritance	(Shi	et	al.,	2017).	Several	genome-wide	association	studies	(GWAS)	also	show	heterozygous	carriers	 of	 the	 polymorphism	 having	 altered	 sleep	 architectures	 (Goel,	2017).	
2.5	Number	of	F1	mice	derived	from	a	single	ENU-treated	mouse	
We	 considered	 the	 maximum	 number	 of	 F1	 mice	 derived	 from	 each	 G0	mouse	based	on	the	diversity	of	the	mutations	in	a	single	G0	mouse	sperm.	Since	 the	 number	 of	 stem	 cell-like	 type	 A-single	 spermatogonia	 (AS)	 is	35,000	per	testis	(Tagelenbosch	and	de	Rooij,	1993)	and	a	single	injection	of	100	 mg/kg	 ENU	 kills	 more	 than	 90%	 AS	 spermatogonia	 (Oakberg	 and	
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Crosthwait,	1983),	three	serial	treatment	results	in	the	survival	of	only	70	AS	spermatogonia.	Since	all	sperm	derived	 from	a	single	spermatogonium	have	 the	 same	 set	 of	 induced	 mutations,	 the	 number	 of	 surviving	spermatogonia	determines	the	number	of	different	sets	of	mutations.		
The	expected	number	of	distinct	mutations	in	F1	mice	derived	from	a	single	G0	mouse,	Nnon-overlapped,	is	theoretically	given	by	
!"#"$#%&'()**&+ = !-* ./ − 1/ − /!-*2!3/4 (1)	where	NF1	and	Nsp	denote	the	number	of	F1	mice	and	the	number	of	AS	in	the	G0	mouse	remaining	after	ENU	treatments,	respectively.	A	formal	derivation	for	this	equation	is	as	follows:		Let	P(M,	NF1)	be	the	probability	of	finding	M	non-overlapping	mutations	in	NF1	individuals.	P(M,	NF1)	satisfies	the	following	recursive	formula,	8(9,;<=) = 8(9,;<= − 1) >?@A + 8(9 − 1,;<= − 1) C1 − >$=?@A D.	Thus,	the	expected	number	of	M,	E[M;	NF1]	(=	Nnon-overlapped),	is	written	as	
E[9;;<=] = I 98(9,;<=)?JK>L= 	
											= 	 I 9?JK>L= N8(9,;<= − 1) 9;OP + 8(9 − 1,;<= − 1) 11 −9 − 1;OP 2Q																																		= E[9;;<= − 1] C1 − =?@AD + 1.		
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By	solving	this	recursive	formula	with	E[M;	0]	=	0	and	E[M;	1]	=	1,	we	obtain	Eq.	(1).		We	calculated	 the	number	of	non-overlapping	mutation	sets	with	varying	number	of	10	to	200	F1	mice	derived	from	an	ENU-treated	male	(NF1)	with	
Nnon-overlapped	for	NSP	=	70	and	70,000	(Figure	6).	When	the	number	of	F1	mice	is	small,	 the	non-overlapping	mutation	sets	 increase	proportionally	to	the	number	of	F1	mice.	As	the	number	of	F1	mice	increases,	the	rate	of	increase	is	 strongly	 suppressed	 by	 overlapping	 mutations.	 For	 this	 reason,	 we	selected	a	moderate	number	of	F1	mice	(N	=	60).	Since	the	effect	of	ENU-treatment	 on	 G0	 mice	 may	 not	 be	 constant,	 the	 number	 of	 overlapped	mutations	 may	 show	 an	 upward	 trend.	 In	 our	 experience,	 the	 identical	mutation	in	the	Sik3	genes	was	confirmed	in	five	pedigrees	derived	from	five	founder	mice	among	60	offspring	of	a	single	G0	male	(Funato	et	al.,	2016).	This	was	an	exceptional	case;	no	such	duplication	has	been	observed	in	other	pedigrees.	 ENU	 might	 have	 particularly	 strong	 effects	 on	 this	 G0	 mouse	leaving	 very	 few	 spermatogonia	 survived,	 which	 severely	 limited	 the	diversity	of	mutations	in	sperms.	
2.6	Sleep/wakefulness	screening	parameters	
Sleep/wake	 parameters	 that	 are	 suitable	 for	 sleep	 phenotyping	 must	 be	highly	 reproducible	 in	 each	mouse.	 Based	 on	 our	 experience,	 qualitative	findings	such	as	a	loss	of	atonia	during	REMS	or	a	disappearance	of	the	theta	wave	during	REMS	 tend	 to	be	stable	 in	 the	same	mouse.	For	quantitative	
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sleep	parameters,	 such	 as	 the	 total	 time	 and	 episode	duration,	we	 tested	reproducibility	in	the	sleep/wakefulness	of	B6J	mice	by	recording	twice	at	more	 than	 four-week	 interval.	 The	 total	 time	 spent	 in	 wakefulness	 and	NREMS	of	each	mouse	in	the	first	recording	significantly	correlated	with	that	in	the	second	recording	(Figure	7A-B),	but	not	in	the	total	REMS	(Figure	7C).	Episode	duration	of	wakefulness	and	NREMS	did	not	reproduce	between	the	first	and	second	recordings	(Figure	7D-E).	Interestingly,	the	REMS	episode	duration	 in	 the	 first	 recording	 significantly	 correlated	 with	 that	 in	 the	second	 recording	 (Figure	 7F).	 The	 total	 time	 spent	 in	 wakefulness	 and	NREMS	 after	 6-h	 of	 sleep	 deprivation	 by	 shaking	 the	 cages	 was	 not	correlated	between	the	first	and	second	recordings	(Figure	5G-H).	The	good	reproducibility	of	the	total	wake	time,	total	NREMS	time	and	REMS	episode	duration	 was	 consistent	 with	 our	 experience	 that	 Sik3Sleepy	 mutant	 and	
NaclnDreamless	mutant	 pedigrees	were	 isolated	 based	 on	 total	wake/NREM	sleep	 time	 and	 REM	 sleep	 episode	 duration,	 respectively	 (Funato	 et	 al.,	2016).	
Moreover,	sleep	parameters	suitable	for	forward	genetics	research	should	exhibit	 minimal	 individual	 variability,	 indicated	 as	 the	 coefficient	 of	variation	 (CV).	 For	 quantitative	 parameters,	 we	 selected	 mice	 with	phenotypes	that	deviated	from	the	average	by	approximately	3	SD	with	good	reproducibility	in	the	second	recording.	A	parameter	with	a	high	CV	is	not	suitable	 for	 behavioral	 screening	 because	 the	 distribution	 of	 mutants	overlaps	with	normal	mice.	For	example,	 the	 circadian	period	 length	was	
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very	tightly	regulated	with	CV	=	0.0072,	which	is	50-fold	lower	than	that	of	fear	conditioning	and	the	psychostimulant	response	(Takahashi	et	al.,	2008),	leading	 to	 successful	 application	 of	 forward	 genetics	 research.	 The	 CV	 of	each	parameters	are	summarized	in	Table	1.	The	smaller	variation	in	total	wake	 time	 (0.11),	 total	 NREMS	 time	 (0.13),	 and	 REMS	 episode	 duration	(0.13)	 may	 further	 corroborate	 the	 successful	 establishment	 of	 Sik3Sleepy	mutant	and	NalcnDreamless	mutant	pedigrees	(Funato	et	al.,	2016).	
Table	1	CV	of	screening	criteria	
 Wake NREMS REMS 
Total time 0.11 0.13 0.21 
Episode duration 0.48 0.27 0.13 
Delta power -- 0.23 -- 
Theta power -- -- 0.24 	The	EEG	delta	density	during	NREM	sleep	and	the	theta	density	during	REM	sleep	also	correlated	well	between	the	first	and	second	recordings	(Figure	5I-J).	 However,	 the	 variances	 were	 large,	 thus	 making	 the	 two	 sleep	parameters	unsuitable	for	forward	genetic	screening.	
2.7	Proof	of	causality	
Almost all phenotype-inducing gene mutations identified in ENU mutagenesis 
are amino-acid changing mutations identified in the coding regions (Beutler et al., 
2007; Simon et al., 2015). Thus,	whole-exome	sequencing	may	be	sufficient	to	detect	responsible	mutations	in	mutant	pedigrees.	Still,	even	though	all	candidate	 mutations	 in	 the	 heritable	 pedigrees	 so	 far	 mapped	 to	 coding	
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regions	in	our	screening,	we	must	consider	the	possibility	that	there	may	be	causal	mutations	outside	coding	regions.	
In	 some	 cases,	 whole-exome	 sequencing	 may	 reveal	 more	 than	 one	candidate	mutations	within	the	mapped	region.	Although	it	is	usually	easy	to	select	one	gene	from	the	candidate	genes	linked	to	the	phenotype,	proving	that	the	other	genes	do	not	affect	the	phenotype	could	be	a	challenge.	For	example,	we	identified	mutations	in	the	Sim1	gene	(Chr10:	50908536)	and	
Sec63	gene	(Chr10:	42816394)	in	an	obesity	pedigree	(Hossain	et	al.,	2016).	Since	 SIM1	 is	 known	 to	 cause	 obesity	 and	 mutant	 SIM1	 protein	 did	 not	function	as	a	transcription	factor,	the	Sim1	mutation	alone	could	explain	the	obesity.	However,	we	could	not	positively	deny	the	possibility	that	mutant	SEC63	 protein,	 which	 is	 involved	 in	 protein	 translocation	 at	 the	 ER	membrane,	may	also	affect	body	weight.	In	such	cases,	one	way	to	establish	causality	would	be	 to	generate	animals	 that	are	 recombinants	across	 this	region;	only	one	mutation	will	consistently	segregate	with	the	phenotype.	
2.8	Probability	of	reaching	significance	
A	QTL	represents	 the	genomic	regions	(loci)	associated	with	a	phenotype	variation	(quantitative	trait).	It	is	carried	out	by	a	statistical	test	to	link	the	genetic	mapping	to	a	trait	to	produce	the	LOD	score	(van	Ooijen,	1999).	High	LOD	 score	 indicates	 a	 high	 probability	 of	 a	 responsible	 gene	 mutation	located	 in	 a	 particular	 chromosomal	 region	 (Wiltshire	 et	 al.,	 2002).	 To	examine	the	relationship	among	the	strength	of	sleep	phenotype,	number	of	
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N2	mice	examined	and	LOD	score,	a	Monte	Carlo	simulation	of	the	LOD	score	was	performed	for	various	population	sizes	of	N2	mice	(NN2	=	60,	80,	and	120).	The	LOD	score	was	computed	based	on	surrogate	data	produced	from	the	empirical	data	(23	control	(+/+)	mice	and	37	mutant	(m/+)	mice)	in	the	following	manner.	
(i) For	each	group,	sample	NN2/2	individuals	from	the	empirical	data	were	 selected	 uniformly	 at	 random	 allowing	 duplication.	 Note	that	here	50%	of	the	population	in	the	surrogate	data	is	set	to	be	mutants.		(ii) The	mean	wake	 time	of	 each	 control	mouse	was	 replaced	by	 a	random	number	sampled	from	a	Gaussian	with	its	mean	and	SD	being	 740	 min	 and	 740	 x	 0.1	 min,	 respectively,	 which	 were	determined	based	on	the	empirical	data.		(iii) Similarly,	we	replaced	the	data	of	the	mutant	group	by	random	numbers	sampled	 from	a	Gaussian,	but	 its	mean	and	SD	(set	 to	mean	x	0.1	based	on	the	F1/N2	male	sleep	data)	were	changed	as	variables.		(iv) For	these	surrogate	data,	we	computed	the	LOD	score	using	the	
R/qtl	 package	 in	 R.	 	 The	 procedures	 (i)	 –	 (iv)	 were	 repeated	10,000	times.	
The	simulation	showed	the	LOD	score	as	a	function	of	the	number	of	mice	examined	 and	 of	 how	 far	 the	mutant	 sleep	 parameter	 deviated	 from	 the	
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mean	 sleep	 parameter	 of	 the	 control	 mice	 (Figure	 8A).	 Importantly,	 the	simulation	also	showed	moderate	variability	in	the	LOD	score	even	under	the	same	condition,	which	may	be	due	to	chance.	One	of	the	Sleepy	pedigrees,	B021,	showed	a	LOD	score	of	32	for	118	N2	mice	(Funato	et	al.,	2016).	The	simulation	predicted	that	a	total	wake	time	of	a	mutant	pedigree	showing	a	LOD	score	of	32	was	approximately	500	min,	which	is	indeed	consistent	with	the	sleep	phenotype	of	Sleepy	pedigrees	(Figure	8A).	
To	 confirm	 the	 causality	 of	 the	 gene	 mutation,	 we	 compare	 the	sleep/wakefulness	 of	 mutant	 mice	 with	 control	 mice.	 We	 simulated	 the	probability	of	reaching	statistical	significance	(P	<	0.05)	in	the	two-sample	
t-test	on	the	mean	wake	time	of	10	control	mice	and	10	mutant	mice.	The	mean	wake	time	of	each	individual	was	randomly	determined	as	described	in	 the	 procedure	 (ii)	 above.	 The	 two-sample	 t-tests	 for	 10,000	 sets	 of	randomly	 generated	 data	was	 performed	 and	 the	 probability	 of	 reaching	statistical	significance	is	shown	in	Fig.	8B.	The	mutant	group	showing	a	mean	daily	wake	time	of	approximately	650	min	and	675	min	showed	80%	and	50%	probability	of	 reaching	 statistical	 significance	 (p<0.05),	 respectively.	However,	when	we	set	the	CV	to	0.15,	which	can	be	found	in	the	literature	(Graves	et	al.,	2003;	Lee	et	al.,	2004),	the	mutant	mean	wake	time	changed	to	 600	 min	 (80%	 chance)	 and	 640	 min	 (50%	 chance),	 indicating	 the	importance	of	highly	consistent	sleep	measurements.	
  30 
2.9	Drowsy	pedigree	carrying	the	Cacna1a	mutation	
The founder male of the B016 (Drowsy) pedigree had a total wake time of 502 
min/24 h. Distribution	of	Drowsy	N2	males	deviated	to	short	total	wake	time	compared	with	unaffected	mice	(Figure	9A).	QTL	analysis	showed	a	single	LOD	 score	 peak	 of	 5.17	 for	 total	 wake	 time	 located	 around	 rs32729089	(chr8:74953357)	 and	 rs33601490	 (chr8:91507617)	 (N	 =	 81,	 Figure	 9B).	According	 to	our	 simulation	 (data	not	 shown),	 the	 total	wake	 time	of	 the	pedigree	showing	a	LOD	score	of	5.2	(N	=	81)	was	expected	to	be	645-680	min,	which	was	60-95	min	shorter	than	the	wild-type	group	mean	(740	min).	Consistently,	 the	 difference	 in	 the	 total	 time	 between	 the	Drowsy	mutant	group	and	the	wild-type	group	was	~70	min.	
Haplotype	 distribution	 of	 affected	 Drowsy	 N2	 mice	 (total	 wake	 time	 in	bottom	20%)	was	different	from	that	of	unaffected	group	(total	wake	time	in	top	20%)	(Figure	9C).	Whole-exome	sequencing	of	the	Drowsy	pedigree	identified	a	heterozygous	single	nucleotide	substitution	(chr8:	84461494)	of	the	Cacna1a	gene	in	7	out	of	8	Drowsy	F1	mice	with	short	total	wake	time	(Figure	9E),	and	direct	sequencing	confirmed	the	nucleotide	change	(Figure	9D).	 CACNA1A	 is	 a	 voltage-dependent	 calcium	 channel	 that	 is	 highly	expressed	 in	 cerebellar	 Purkinje	 cells	 and	 many	 other	 types	 of	 neurons	(Rajakulendran	 et	 al.,	 2012).	 The	 mutation	 results	 in	 an	 amino	 acid	substitution	F102L	in	the	first	transmembrane	region	of	domain	I	(Figure	9F),	well-conserved	among	vertebrates	and	invertebrates	(Figure	9G).	Many	
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missense	 mutations	 in	 Cacna1a	 are	 associated	 with	 two	 autosomal	dominant	diseases,	episodic	ataxia	type2	and	familial	hemiplegic	migraine,	as	well	 as	 spinocerebellar	 ataxia	 6	 caused	 by	 a	 CAG	 repeat	 expansion	 in	
Cacna1a	 (Figure	 9F)	 (Rajakulendran	 et	 al.,	 2012).	 As	 predicted,	 the	homozygous	 Drowsy	 mutant	 suffered	 from	 severe	 abnormalities	 in	locomotion	 and	 posture	 which	 was	 reported	 in	 Cacna1a-deficient	 mice	(Fletcher	 et	 al.,	 2001;	 Jun	 et	 al.,	 1999).	 Notably,	 a	 recent	 computational	simulation-based	 study	 showed	 the	 potential	 role	 of	 voltage-dependent	calcium	channel	in	sleep/wake	maintenance	(Tatsuki	et	al.,	2016).	 	
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SECTION	III:		MATERIALS	AND	METHODS	
	
Animals	All	procedures	were	conducted	in	accordance	with	the	Guidelines	for	Animal	Experiments	 of	 University	 of	 Tsukuba	 and	 approved	 by	 the	 Institutional	Animal	 Care	 and	 Use	 Committee	 of	 University	 of	 Tsukuba	 (Approved	protocol	ID	#140200).	B6J	and	B6N	mice	were	obtained	from	CLEA	Japan	and	Charles	River.	B10J	mice	were	from	The	Jackson	Laboratory	(#000665).	Mice	were	housed	in	a	polysulfone	cage	(391	x	199	x	160	mm,	floor	area	501	cm2,	Techniplast	#GM500)	in	individually	ventilated	cage	racks	(Techniplast	#DGM70QX)	under	controlled	conditions	(12-h	 light/dark	cycle,	23	±	2°C,	55	 ±	 5%	 humidity,	 and	 ad	 libitum	 access	 to	water	 and	 food).	Mice	were	weaned	at	4	weeks	of	age	and	housed	in	groups	of	up	to	5	mice	per	cage.			
In	vitro	fertilization	Sperms	from	mutagenized	G0	mice	were	harvested	at	the	age	of	25-30	weeks	and	 cryopreserved	 until	 use.	 To	 induce	 superovulation,	 adult	 female	C57BL/6N	 mice	 were	 administered	 with	 pregnant	 mare	 serum	gonadotropin	 followed	 by	 human	 chorionic	 gonadotropin	 (hCG)	 at	 48-h	intervals.	 Approximately	 15-17	 h	 after	 hCG	 treatment,	 we	 removed	 the	oviducts	 from	 superovulated	mice	 and	 collected	 the	 oocytes.	 The	 pooled	oocytes	obtained	from	20	females	were	inseminated	with	capacitated	sperm.	After	 overnight	 culture,	 two-cell	 stage	 embryos	 were	 transferred	 into	
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pseudopregnant	recipient	females.	To	avoid	overrepresentation	of	the	same	mutations	 in	 sperm	 differentiated	 from	 the	 same	 spermatogonia,	 60	 or	fewer	F1	males	from	a	single	G0	mouse	were	used	for	phenotypic	screening.	
	
EEG/EMG	electrode	and	tether	cable.	Each	electrode	is	composed	of	an	insulator	(length	7.62	x	width	6.08	x	height	8.26	mm)	with	four	metal	pins	(0.50	x	0.40	x	2.6	mm)	that	are	5.08	mm	apart	in	the	anteroposterior	axis	and	2.54	mm	in	the	left-right	axis.	Two	15-mm-long	Teflon-coated	stainless	wires	(Cooner	wire	#AS633)	extends	from	the	center	 equidistance	 from	 the	metal	 pins	 (Figure	 10A).	 The	 Teflon-coat	 is	removed	2	mm	from	the	free	end	of	the	EMG	wires	and	fused	using	lead-free	solder.	Four	metal	pins	and	EMG	wires	are	gold-plated	by	immersing	them	in	Supermex	#250	(Metalor	Technologies).		The	electrode-end	of	a	tether	is	composed	of	a	6-pin	header	(dissected	from	2	 x	 40	 pin	 header,	 Useconn	 Electronics	 Ltd.,	 #PH-2x40SG)	 with	 the	 two	outermost	left-side	pins	for	the	EEG	signals	and	two	middle	pins	for	the	EMG	signals	(Figure	10B).	The	pin	unit	 is	covered	with	epoxy	resin	(Cemedine,	High	Super	30	#CA-193)	or	a	heat-shrinkable	tube	(5	mm	in	diameter,	black;	Sumitomo	 Electric,	 SUMITUBE®	 C).	 The	 other	 end	 of	 the	 tether	 cable	 is	composed	of	 a	 slip	 ring	 (yosoo	#yosoo-811-3,	diameter	12.5mm)	or	 cord	detangler	(Phillips	#SJA4150/17),	which	allows	the	mouse	to	move	freely	in	a	recording	cage.	The	electrode/tether	unit	is	connected	to	a	cable	via	4-pin	RJ11	plug	that	transmits	signals	to	a	preamplifier	(Figure	10C).	
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EEG/EMG	electrode	implantation	surgery	Eight-	 to	 ten-week-old	 mice	 (body	 weight	 >25	 g)	 were	 subjected	 to	EEG/EMG	 electrode	 implantation	 surgery.	 The	 surgery	 was	 performed	under	 isoflurane	 anesthesia	 (4%	 for	 induction,	 2%	 for	maintenance).	 An	incision	was	made	on	 the	 scalp	 along	 the	midline	 to	 expose	 the	 cranium.	Four	 holes	 were	 made	 on	 the	 skull	 using	 1.0-mm	 dental	 drill	 bits	(anteroposterior:	 0.50	mm,	 lateral:	±1.27	mm	and	 anteroposterior:	 −4.53	mm,	lateral:	±1.27	mm	from	bregma).	The	electrode	pins	were	lowered	onto	the	dura	under	stereotaxic	control	(David	Kopf	Instruments	#940/926)	and	fixed	using	dental	cement	(3M	ESPE,	Ketac	Cem	Aplicap).	Subsequently,	two	EMG	wires	were	crossed	once,	inserted	into	the	neck	extensor	muscles	and	covered	with	dental	cement.	The	skins	is	,	then,	sutured	to	close	the	incision.	A	6-pin	header	(dissected	from	2	x	40	pin	header,	Useconn	Electronics	Ltd.,	#PH-2x40SG)	was	inserted	into	the	top	of	the	EEG/EMG	electrode	to	close	the	holes	of	the	insulator.		
EEG/EMG	Recording	Seven	days	after	 surgery,	 the	mice	were	attached	 to	a	 tether	 cable	under	isoflurane	anesthesia,	then	single-housed	in	a	recording	cage	(19.1	x	29.2	x	12.7	cm).	The	tether	cable	was	hung	by	a	counterbalanced	lever	arm	(11.4	cm-long,	Instech	Laboratories	#MCLA)	that	allows	the	mice	to	move	freely.	All	mice	were	given	at	least	5	days	of	recovery	from	surgery	and	habituation	
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to	the	recording	conditions	for	additional	4	days	at	the	minimum.	The	floor	of	 the	cage	was	covered	with	aspen	chips	and	nest	materials.	To	examine	sleep/wake	behavior	under	baseline	 conditions,	 the	EEG/EMG	signal	was	recorded	for	three	consecutive	days	from	the	onset	of	the	light	phase.	Mice	were	deprived	of	sleep	from	ZT0	to	ZT6	by	intermittent	mechanical	agitation	of	 the	 cages	 (Sinton	et	 al.,	 2009)	and	 subsequently	 recorded	 from	ZT6	 to	ZT24	for	18-h.	
	
EEG/EMG	analysis	EEG/EMG	signals	were	amplified,	filtered	(EEG:	0.3–300	Hz;	EMG:	30–300	Hz)	with	a	multi-channel	amplifier	(NIHON	KODEN,	#AB-611J),	and	digitized	at	a	sampling	rate	of	250	Hz	using	an	analogue-to-digital	converter	(National	Instruments	 #PCI-6220)	 with	 LabVIEW	 software	 (National	 Instrument).	The	 EEG/EMG	 data	 were	 visualized	 and	 semi-automatically	 analyzed	 by	MATLAB-based	software	followed	by	visual	inspection.	Each	20-sec	epoch	was	staged	into	wakefulness,	NREM	sleep	and	REM	sleep.	Wakefulness	was	scored	based	on	the	presence	of	low	amplitude,	fast	EEG	activity	and	high	amplitude,	 variable	 EMG	 activity.	 NREM	 sleep	was	 characterized	 by	 high	amplitude,	 delta	 (1–4	 Hz)-frequency	 EEG	 waves	 and	 a	 low	 EMG	 tonus,	whereas	 REM	 sleep	 was	 staged	 based	 on	 theta	 (6–9	 Hz)-dominant	 EEG	oscillations	 and	 EMG	 atonia.	 The	 total	 time	 spent	 in	 wakefulness,	 NREM	sleep,	and	REM	sleep	was	summed	as	the	total	number	of	20-s	epochs	in	each	state.	Mean	episode	durations	were	determined	by	dividing	the	total	time	
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spent	 in	 each	 state	 by	 the	 number	 of	 episodes	 of	 that	 state.	 Epochs	 that	contained	movement	artifacts	were	included	in	the	state	totals	but	excluded	from	the	subsequent	spectral	analysis.	EEG	signals	were	subjected	 to	 fast	Fourier	transform	analysis	from	1	to	30	Hz	with	1-Hz	bins	using	MATLAB-based	custom	software.	The	EEG	power	density	in	each	frequency	bin	was	normalized	to	the	sum	of	16-30	Hz	in	all	sleep/wake	state.		
Linkage	analysis	using	SNPs	between	C57BL/6J	and	C57BL/6N	We	 sequenced	 SNPs	 of	 C57BL/6JJcl,	 C57BL/6NJcl,	 C57BL/6NCrl,	 and	C57BL/6NCrlCrlj	 to	 select	 96	 SNPs	 of	 C57BL/6JJcl	 that	 differ	 from	C57BL/6NJcl,	 C57BL/6NCrl	 and	 C57BL/6NCrlCrlj	 (Table	 1,	 Figure	 2)	(Kumar	et	al.,	2013).	DNA	was	purified	from	tails	of	mice	using	a	Qiagen	kit	(DNeasy	Blood	&	Tissue	Kit,	QIAGEN	#69504).	SNPs	between	C57BL/6J	and	C57BL/6N	of	N2	mice	were	determined	using	a	custom	TaqMan	Genotyping	assay	 (Thermo	 Fisher).	 The	 QTL	 analysis	 was	 performed	 using	 R/qtl	software	(version	1.42-8;	www.rqtl.org)	(Broman	et	al.,	2003).	
	
Whole-exome	sequencing	Exome	sequencing	libraries	were	prepared	with	the	SeqCap	EZ	Developer	Library	kit	(MM10	exome,	cat#	110624,	Roche	NimbleGen)	from	500	ng	of	genomic	DNA	 to	 determine	 the	 number	 of	mutations	 in	 the	mutagenized	mice.	 Sequencing	 of	 the	 multiplexed	 library	 using	 the	 151x2	 paired-end	mode	 in	 the	 NextSeq	 500	 sequencer	 (Illumina)	 was	 performed	 by	 i-
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Laboratory	LLP	sequencing	service	(Tsukuba,	Japan).	Reads	in	FASTQ	files	were	imported	into	the	CLC	Genomics	Workbench	(Qiagen),	trimmed	by	1-base	 at	 the	 3'	 end,	 and	 mapped	 to	 the	 mm10	 mouse	 reference,	 which	represents	the	C57BL/6J	strain	genome.	Exome	sequencing	statistics	were	calculated	to	capture	the	target	region	definition	provided	by	the	SeqCap	kit.	Variant	 calls	 were	 performed	 using	 the	 Basic	 Variant	 Detection	 tool.	Potential	 variants	 were	 filtered	 against	 control	 mouse	 variants.	Nonsynonymous	base	substitutions	and	small	InDels	were	identified	based	on	ENSEMBLE	transcript	annotation.	For	 the	B016	pedigree,	whole	 exomes	were	 captured	with	SureSelectXT2	Mouse	All	Exon	(Agilent)	and	processed	to	a	paired-end	2	x	100-bp	run	on	the	Illumina	HiSeq2000	platform	at	 the	University	of	Texas	Southwestern	Medical	Center,	Next	Generation	Sequencing	Core.	Reads	were	mapped	to	the	University	of	California	Santa	Cruz	mm9	genome	reference	sequence	for	C57BL/6J	 using	 Burrows-Wheeler	 Aligner	 and	 quality	 filtered	 using	SAMtools.	Cleaned	BAM	files	were	used	to	realign	the	data	and	call	variants	using	the	Genome	Analysis	Tool	Kit	to	detect	heterozygous	mutations.		
Genotyping	To	 detect	 a	 single	 nucleotide	 change	 as	 routine	 genotyping,	we	 used	 the	dCAPS	method	in	which	PCR	products	are	digested	by	restriction	enzymes	(Neff	et	al.,	2002).	dCAPS	Finder	(http://helix.wustl.edu/dcaps/dcaps.html)	was	used	to	design	the	primers.	
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Statistics	Statistical	 analysis	 was	 performed	 using	 SPSS	 Statistics	 22	 (IBM)	 and	 R	software.	All	data	were	tested	for	a	Gaussian	distribution	and	variance.	We	used	 one-way	 analysis	 of	 variance	 (ANOVA)	 followed	 by	 Tukey’s	 test	 to	assess	sleep	parameters	of	mouse	substrains.	To	assess	the	reproducibility	of	 the	 sleep	 parameters,	 data	 from	 the	 first	 and	 second	 recordings	were	analyzed	 using	 Pearson’s	 correlation	 test.	 P	 <	 0.05	 was	 considered	statistically	significant.	
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SECTION	IV:		CONCLUSION	
 We	described	the	method	for	EEG/EMG-based	sleep	screening	of	randomly	mutagenized	 mice	 and	 discussed	 the	 selection	 of	 inbred	 mouse	 strains.	Statistically	examined	reproducibility	of	the	selected	screening	parameters	proved	 the	 precision	 of	 the	 sleep/wake	 measurement.	 Furthermore,	 we	showed	the	workflow	for	identifying	the	causative	gene;	as	an	example,	the	identification	of	a	Cacna1a	mutation	in	the	Drowsy	pedigree	showing	a	mild	hypersomnia	phenotype.	
At	the	scale	of	~10,000	mice,	we	identified	10	heritable	loci	to	date.	While	low	 occurrence	 of	 sleep	 phenodeviant	 was	 expected,	 possibly	 due	 to	redundant	 regulatory	 mechanisms	 in	 sleep/wakefulness	 and	 low	penetrance	of	the	phenotype,	our	screening	output	seems	to	be	comparable	to	other	 trials	where	a	 single	biological	 trait	 is	 screened	 (Vitaterna	et	 al.,	2006).	 The	 Clock	 ENU	 mutant	 is	 a	 lucky	 example	 that	 found	 the	 causal	mutation	from	screening	304	G1	progeny	(Vitaterna	et	al.,	1994).	Daxinger	
et	al.	reported	identification	of	a	single	candidate	gene	from	a	population	of	2,045	 G1	mice	 (Daxinger	 et	 al.,	 2013).	 Another	 study	 showed	 20	mutant	progeny	 that	 carry	 10	 unique	 gene	 mutations	 from	 screening	 of	approximately	5,000	G1	offspring,	of	which	9	were	previously	known	genes	in	epigenetic	regulation	(Furuse	et	al.,	2010).	
  40 
The	 identified	 genes	 in	 our	 study	 usually	 encode	 proteins	 with	 large	molecular	 weights,	 probably	 because	 the	 cumulative	 frequency	 of	 ENU-induced	mutation	is	proportional	to	the	gene	size	(Bauer	et	al.,	2015);	some	of	known	sleep	regulatory	genes,	such	as	the	very	compact	orexin	and	orexin	receptor	genes,	have	not	been	detected	in	this	screening.	Also,	for	unknown	reasons,	 the	 majority	 of	 our	 sleep	 phenodeviants	 has	 been	 long-sleep	mutants.	
Phenotype-driven	screening	at	 such	 large	 scale,	 indeed,	 is	 labor-intensive	and	 costly.	 It	 is	 not	 recommended	 for	 an	 attempt	 to	 furthering	 the	knowledge	of	 largely	defined	mechanisms	 since	 there	 is	 a	 high	 chance	of	identifying	already	known	genes,	as	it	was	the	case	of	our	obesity	screening	(Hossain	et	al.,	2016).	Also,	in	a	dominant	screening	we	recommend	a	highly	focused	screen	rather	than	trying	to	examine	multiple	biological	traits	in	a	workflow;	after	all,	the	most	expensive	step	in	the	screening	is	phenotyping,	not	the	production	of	mutagenized	mice.	It	is	difficult	to	draw	estimation	on	further	identification	of	candidate	genes	and	whether/when	saturation	can	be	 reached	 in	 a	 dominant	 screen	 (Nolan	 et	 al.,	 1997).	 Nevertheless,	 we	should	find	more	genes	in	sleep/wake	regulation	by	enlarging	the	scale	and	continuing	 the	 search.	 The	 screening	 strategy	 is	 easily	 modifiable	 for	studying	other	physiological	phenomena	in	mice	with	careful	selection	of	the	screening	criteria	and	the	biology	to	be	studied.			 	
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SECTION	V:		FIGURES	AND	TABLES	
 	
Abbreviations for the substrain genealogy: N, National Institutes of Health; J, 
Jackson Laboratory; Crl, Charles River Laboratories; Crlj, Charles River 
Laboratories Japan; Jcl, CLEA Japan. (Jackson Laboratory, https://www.jax.org) 
 
 
  
Figure	1	Phylogenetic	tree	of	C57BL	substrains	
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Figure	2	Chromosomal	location	of	SNPs	for	linkage	analysis		
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Figure	3	Sleep	parameters	in	B6J,	B6N	and	B10J.		
Total time spent in (A) wake (B) NREMS and (C) REMS. Episode duration 
during (D) wake, (E) NREMS and (F) REMS. EEG power spectrum during (G) 
NREMS and (H) REMS. (I) The delta density (1-4 Hz) during NREMS and (J) 
the theta density (6-9 Hz) during REMS. Male B6J (N = 21), B6N (N = 20) and 
B10J (N = 20). All data are shown as the mean ± SEM *P < 0.05; **P < 0.01; 
***P < 0.001; ****P < 0.0001. Two-way ANOVA followed by Tukey’s test (A-
H). One-way ANOVA followed by Tukey’s test (I, J) 
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Figure	4	Recovery	sleep	after	6-h	sleep	deprivation.		
(A) Wake, (B) NREMS, (C) REMS during 18-h recovery following 6-h sleep 
deprivation. (D) NREMS EEG delta decay during the 18-h recovery. Recovery 
delta power is normalized by the last hour of the light phase (ZT11) of the 
baseline. Red-filled box, 6-h sleep deprivation; white box, 6-h recovery sleep; 
gray-filled box, 12-h dark phase. (E) Change, shown as ratio (recovery/baseline), 
in time spent in each vigilance state during dark phase (ZT12-ZT24). Male B6J 
(N = 19), B6N (N = 18) and B10J (N = 20). All data are shown as the mean ± 
SEM *P < 0.05; ** (blue) P < 0.01; *** (green) P < 0.001; **** (red) P < 0.0001. 
Two-way ANOVA followed by Tukey’s test. 
 
 	
18 h Light Dark
0
200
400
600
m
in
18-h Recovery wake time
B6J
B6N
B10J
0 4 8 12 16 20 24
0
1
2
3
R
el
at
iv
e 
de
lta
 p
ow
er
 
Recovery NREMS delta decay
B6J vs. B6N
B6J vs. B10J
B6N vs. B10J
18 h Light Dark
0
200
400
600
m
in
18-h Recovery NREMS time
18 h Light Dark
0
20
40
60
80
100
m
in
18-h Recovery REMS time
Wake NREMS REMS
0
1
2
3
4
5
R
el
at
iv
e 
ch
an
ge
Change during dark phase (ZT12-24)
A B
C D
E
  45 
Figure	5	Screening	strategy	in	sleep	and	wake	behavior	
(A) Recessive screening scheme. In an intercross scheme (shaded), a sibling 
mating between heterozygous G2 male and female is used to produce G3 
generation. In a backcross scheme (dotted), G1 founder is crossed with G2 mutant 
daughter. (B) In the dominant screening, each F1 phenodeviant is crossed with 
female wild-type B6N mice to obtain N2 mice. Male N2 mice are examined 
whether the sleep abnormality is heritable. If heritability is confirmed, N2 mice 
are used for QTL analysis and whole-exome sequencing to identify the gene 
mutation associated with the sleep phenotype. (C) Examples of heritability test 
results. Phenodeviant A: normal sleep phenotype; sleep parameter histogram in 
N2 mice showing similar trend as the normal population (+/+, green). 
Phenodeviant B: subtle sleep phenotype, heritability cannot be determined (?/+, 
yellow). Phenodeviant C: heritable and weak sleep phenotype. Many N2 mice (? 
/+) cannot be determined as either phenodeviant (m/+) or normal (+/+) based on 
the sleep behavior. Phenodeviant D: heritable and strong sleep phenotype. Each 
N2 mouse can be assigned as either phenodeviant (m/+) or normal (+/+). 
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Figure	6	Number	of	non-overlapped	mutations	The	 expected	 number	 of	 non-overlapped	 F1	mutant	mice	 derived	 from	 a	single	 G0	mouse	 for	Nsp=70,	when	 three	 ENU	 treatments	 killed	 99.9%	of	stem-cell-like	spermatogonia	(red	curve).	For	reference,	the	results	for	Nsp	=	70,000	 (when	all	 stem-cell-like	 spermatogonia	 in	 two	 testes	 survived	 the	ENU	treatments)	is	also	shown	(blue	line).		
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Figure	7	Reproducibility	of	the	sleep	parameters	Reproducibility	 of	 sleep	 parameters	 between	 basal	 recording	 (1st)	 and	second	recording	(2nd).	Total	time	in	(A)	wake,	(B)	NREMS	and	(C)	REMS.	Episode	duration	of	(D)	wake,	(E)	NREMS,	and	(F)	REMS.	Total	time	during	18	h	after	6-h	sleep	deprivation	in	(G)	wake	and	(H)	NREMS.	(I)	Delta	Density	(1-4	Hz)	during	NREMS	and	(H)	theta	density	(6-9	Hz)	during	REMS.	B6N	(N	=	37).	Each	line	indicates	a	regression	line.	Pearson’s	correlation	coefficient	(r)	and	probability	(P)	are	indicated.	
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Figure	8	Simulation	of	statistical	tests.	(A)	The	LOD	score	computed	 for	 surrogate	data	with	various	mean	wake	time	of	the	mutant	group	of	60	(blue),	and	120	(red)	N2	mice.	The	lines	and	shaded	 areas	 indicate	 the	 averages	 and	 95%	 confidence	 intervals	 of	 the	obtained	 LOD	 score	 calculated	 based	 on	 10,000	 sets	 of	 surrogate	 data,	respectively.	In	each	case,	we	assumed	that	50%	of	population	were	mutants.	The	black	square	in	panel	(A)	indicates	the	Sleepy	mutant	pedigree,	B021.	(B)	The	probability	of	reaching	statistical	significance	in	a	two-sample	t-test	on	the	mean	wake	time	of	10	control	and	10	mutant	mice.	The	results	were	averaged	over	10,000	trials.	
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Figure	9	Identification	of	the	Cacna1a	gene	mutation	in	the	Drowsy	
pedigree	(A)	 Wake	 time	 distribution	 of	 retrospectively	 genotyped	 Drowsy	 N2	littermates.	Cacna1a+/+	(blue)	and	Cacna1am/+	(red)	mice.	(B)	QTL	analysis	of	the	Drowsy	pedigree	for	total	wake	time	(N	=	81).	(Inset)	LOD	score	peak	between	 rs13479672	 and	 rs33601490	 on	 chromosome	 8.	 (C)	 Haplotype	analysis	of	Drowsy	mutant	pedigrees	with	sleepy	phenotypes	(bottom	20%	in	total	wake	time)	and	without	a	sleepy	phenotype	(top	20%	in	total	wake	time).	(D)	Direct	sequencing	of	the	Cacna1a	gene	in	Cacna1a+/+,	Cacna1am/+	and	Cacna1am/m	mice.	(E)	Mutational	analysis	of	affected	mice	(bottom	20%	in	total	wake	time)	and	unaffected	mice	(top	20%	in	total	wake	time)	within	the	Drowsy	pedigree.	(F)	Structures	of	the	CACNA1A	protein	indicating	the	current	F102L	mutation	and	selected	human	missense	mutations	reported	in	familial	hemiplegic	migraine	(yellow)	and	episodic	ataxia	type2	(green)	and	polyglutamine	in	spinocerebellar	ataxia	type	6	(Gln). (G)	Phylogenetic	conservation	around	phenylalanine	102.	
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Figure	10	Design	of	the	electrode	and	cables.	(A)	Bottom,	side	and	front	views	of	an	electrode	for	EEG	and	EMG.	Four	EEG	electrodes	and	one	end	of	two	EMG	wires	are	gold-plated.	Two	of	four	EEG	electrodes	are	actually	used	to	obtain	the	EEG	signal.	Four	protrusions	close	to	 each	EEG	electrode	 enable	 fixation	of	 the	position	of	 an	 electrode	 at	 a	certain	depth	during	 implantation	 surgery.	 The	unit	 for	measurements	 is	millimeters.	(B)	A	tether	cable	connects	an	EEG/EMG	electrode	and	a	cable	that	is	connected	to	a	preamp.	The	top	of	the	tether	cable	is	composed	of	a	4-pin	detangler.	(C)	A	cable	transmits	EEG/EMG	signal	from	the	tether	cable	to	a	preamp.		
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Table	2.	SNP	list	for	linkage	analysis	of	C57BL/6J	and	C57BL/6N	
substrains	
 
Chromosome Position(mm10) rs number B6J B6N 
Chr1 1:3607559 rs32685032 A T 
Chr1 1:42367595 rs31362610 T C 
Chr1 1:88806692 rs242608911 C T 
Chr1 1:129386361 rs6327099 T C 
Chr1 1:163132699 rs6341208 A T 
Chr1 1:194246275 rs242712390 C A 
Chr2 2:8069855 rs13476337 A T 
Chr2 2:45143008 rs33488914 A G 
Chr2 2:78799176 rs33162749 C T 
Chr2 2:106074143 rs227312316 G A 
Chr2 2:138480020 rs13476801 T C 
Chr2 2:179262364 rs29673978 T C 
Chr3 3:5370727 rs13476956 C T 
Chr3 3:27240831 rs237712466 T G 
Chr3 3:54425630 rs31338752 A G 
Chr3 3:74118533 rs31154737 A T 
Chr3 3:107470377 rs31321678 A G 
Chr3 3:152219576 rs31594267 A C 
Chr4 4:6374701 rs32143059 G A 
Chr4 4:28322410 rs13477622 T C 
Chr4 4:65944235 rs13477746 T C 
Chr4 4:110650398 rs245725397 C T 
Chr4 4:132595336 rs46988409 C A 
Chr4 4:155910817 rs6397070 T C 
Chr5 5:4547791 rs247844351 C T 
Chr5 5:40761789 rs33508711 C T 
Chr5 5:70742061 rs13478320 C A 
Chr5 5:92081078 rs33249065 A G 
Chr5 5:117459347 rs3662161 A G 
Chr5 5:149626021 rs33208334 T C 
Chr6 6:6233941 rs30450019 A G 
Chr6 6:44286336 rs30892442 A C 
Chr6 6:80305689 rs48566826 T A 
Chr6 6:117470880 rs13478995 C G 
Chr6 6:141072590 rs235068709 G T 
Chr7 7:6976737 rs242748489 G A 
Chr7 7:37431938 rs31221380 A C 
Chr7 7:71816909 rs32060039 C G 
Chr7 7:104047611 rs46252790 G A 
Chr7 7:129035694 rs13479522 A G 
Chr8 8:10521755 rs13479605 C A 
Chr8 8:29097075 rs13479672 T C 
Chr8 chr8:56318886 rs32785829 A G 
Chr8 8:91507617 rs33601490 T C 
Chr8 8:123630996 rs32577205 A G 
Chr9 9:6238770 rs33672596 A G 
Chr9 9:31156626 rs13480122 T C 
Chr9 9:52785119 rs29644859 T G 
Chr9 9:85239185 rs260373537 T C 
Chr9 9:119641498 rs30431245 T C 
Chr10 10:5030776 rs50477269 A G 
Chr10 10:33653023 rs13480575 T C 
Chr10 10:57752462 rs13480619 T C 
Chr10 10:80795365 rs13459122 A T 
Chr10 10:109378627 rs13480759 C T 
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Chr11 11:4508730 rs3659787 G A 
Chr11 11:21140133 rs29413390 A G 
Chr11 11:48117382 rs13481014 T C 
Chr11 11:79252230 rs13481117 G T 
Chr11 11:120306788 rs49027247 T C 
Chr12 12:7453718 rs29142759 A G 
Chr12 12:34467966 rs29487143 G C 
Chr12 12:62767534 rs29133146 A C 
Chr12 12:85645337 rs13481569 G A 
Chr12 12:106833655 rs13481634 A C 
Chr13 13:18724094 rs29242536 A G 
Chr13 13:41442786 rs3722313 T C 
Chr13 13:77411106 rs29802434 G C 
Chr13 13:101209232 rs3702296 A G 
Chr14 14:9937385 rs31187642 G A 
Chr14 14:36479449 rs31133670 A G 
Chr14 14:74415721 rs30264676 T A 
Chr14 14:99624996 rs31059846 A G 
Chr14 14:124108797 rs31233932 C T 
Chr15 15:9757093 rs257670740 T C 
Chr15 15:30613567 rs261563123 C T 
Chr15 15:71632551 rs31858887 T C 
Chr15 15:97255365 rs31921278 A G 
Chr16 16:4238020 rs4152511 T C 
Chr16 chr16:32451615 rs257082658 T G 
Chr16 16:52739944 rs4187179 T C 
Chr16 16:87819629 rs4214728 T C 
Chr17 17:5332903 rs4137196 T C 
Chr17 17:39170355 rs33334258 G A 
Chr17 17:60319945 rs13483055 T C 
Chr17 17:93830797 rs33132419 T C 
Chr18 18:15249748 rs13483221 C T 
Chr18 18:35206506 rs13483296 A T 
Chr18 18:54614841 rs13483369 A C 
Chr18 18:84516845 rs29690544 T C 
Chr19 19:9027005 rs31112038 G C 
Chr19 19:21913323 rs45985634 A T 
Chr19 19:38005411 rs30953636 G T 
Chr19 19:49976154 rs3724876 G T 
Chr.20 (X) X:17562057 rs31353361 T C 
Chr.20 (X) X:57867627 rs6368704 A G 
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